Chemistry of the fructosamine assay: D-glucosone is the product of oxidation of Amadori compounds.

The chemistry of the fructosamine assay was studied by using the Amadori compound, N alpha-formyl-N epsilon-fructose-lysine (fFL), an analog of glycated lysine residues in protein. Previously (Clin Chem 1993;39:2460-5), we reported that free lysine was formed from fFL at 70% yield during incubation with alkaline nitroblue tetrazolium (NBT) under the conditions routinely used for the fructosamine assay (sodium carbonate buffer, pH 10.35 at 37 degrees C). Here, we show that D-glucosone is the primary carbohydrate oxidation product formed from Amadori compounds in the fructosamine assay. Glucosone, which decomposes under alkaline assay conditions with a half-life of < 30 min, reaches a maximum concentration of approximately 50% of the initial fFL concentration after 10 min of incubation. Like fFL, glucosone reduces NBT to the purple monoformazan dye, but its decomposition is not accelerated by the presence of NBT. The dicarbonyl-trapping reagent, aminoguanidine, inhibits the fructosamine assay by approximately 25% when fFL is the substrate, but by nearly 100% with glucosone as substrate. Studies with serum samples from diabetics and nondiabetics indicate that glucosone formation does not have a significant effect on the clinical usefulness of the fructosamine assay; however, corrections for glucosone formation may be required when the assay is used for estimating the extent of glycation of proteins.

[1]  J. Baynes,et al.  Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. , 1986, The Journal of biological chemistry.

[2]  D. Knapp,et al.  Handbook of Analytical Derivatization Reactions , 1980 .

[3]  J. Baynes,et al.  Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo. , 1992, Archives of biochemistry and biophysics.

[4]  K. Uchida,et al.  Oxidative Damage of Glycated Protein in the Presence of Transition Metal Ion , 1991 .

[5]  S. Wolff,et al.  Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. , 1993, Biochemical pharmacology.

[6]  J. Baynes,et al.  Mechanism of fructosamine assay: evidence against role of superoxide as intermediate in nitroblue tetrazolium reduction. , 1993, Clinical chemistry.

[7]  M. Namiki,et al.  A New Mechanism of the Maillard Reaction Involving Sugar Fragmentation and Free Radical Formation , 1983 .

[8]  K. Uchida,et al.  Autoxidative degradation of Amadori compounds in the presence of copper ion , 1991 .

[9]  J. Baynes,et al.  Oxidative degradation of glucose adducts to protein. Formation of 3-(N epsilon-lysino)-lactic acid from model compounds and glycated proteins. , 1988, The Journal of biological chemistry.

[10]  Paul J Thornalley,et al.  The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions. , 1984 .

[11]  P. Metcalf,et al.  Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[12]  J. Hodge,et al.  The Amadori rearrangement. , 1955, Advances in carbohydrate chemistry.

[13]  M. Namiki,et al.  Development of novel free radicals during the amino-carbonyl reaction of sugars with amino acids , 1975 .

[14]  H. Kato.  Chemical Studies on Amino-carbonyl Reaction:Part II. Identification of D-Glucosone Formed by Oxidative Browning Degradation of N-D-Glucoside , 1963 .

[15]  P. Finot,et al.  Le blocage de la lysine par la réaction de MAILLARD. I. Synthèse de N‐(désoxy‐1‐D‐fructosyl‐1)‐ et N‐(désoxy‐1‐D‐lactulosyl‐1)‐L‐lysines , 1969 .

[16]  J. Baynes,et al.  The reaction of 3-deoxy-D-glycero-pentos-2-ulose ("3-deoxyxylosone") with aminoguanidine. , 1991, Carbohydrate research.

[17]  J. Baker,et al.  Use of protein-based standards in automated colorimetric determinations of fructosamine in serum. , 1985, Clinical chemistry.